Vitamin D metabolites and fibroblast growth factor-23 in patients with left ventricular assist device implants: association with stroke and mortality risk

European Journal of Nutrition

Volumn 55, Issue 1, 2016, Pages 305-313

  Zittermann, A ^a   Morshuis, M ^a   Kuhn, J ^a   Pilz, S ^b   Ernst, J B ^a   Oezpeker, C ^a   Dreier, J ^a   Knabbe, C ^a   Gummert, J F ^a   Milting, H ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

1,25 dihydroxyvitamin D; 25 hydroxyvitamin D; Fibroblast growth factor 23; Mortality; Stroke; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; TACALCITOL; VITAMIN D DERIVATIVE; FIBROBLAST GROWTH FACTOR; VITAMIN D;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; FEMALE; HIGH RISK PATIENT; HUMAN; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK REDUCTION; BIOASSAY; BLOOD; COMPLICATION; FOLLOW UP; HEART ASSIST DEVICE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; ENDPOINT DETERMINATION; FEMALE; FIBROBLAST GROWTH FACTORS; FOLLOW-UP STUDIES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARATHYROID HORMONE; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84957426037     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-0847-8     Document Type: Article

References (40)

1. Hunt SA (2006) Taking heart: cardiac transplantation past, present, and future. N Engl J Med 355:2315
2. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L (2008) Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 86:1227–1234
3. Slaughter MS, Meyer AL, Birks EJ (2011) Destination therapy with left ventricular assist devices: patient selection and outcomes. Cur Opin Cardiol 26:232–236
4. Kato TS, Schulze PC, Yang J, Chan E, Shahzad K, Takayama H, Uriel N, Jorde U, Farr M, Naka Y, Mancini D (2012) Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. J Heart Lung Transplant 31:1–8
5. Boyle AJ, Jorde UP, Sun B, Park SJ, Milano CA, Frazier OH, Sundareswaran KS, Farrar DJ, Russell SD, HeartMate II Clinical Investigators (2014) Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol 63:880–888
6. Zittermann A, Fuchs U, Kuhn J, Dreier J, Schulz U, Gummert JF, Börgermann J (2011) Parameters of mineral metabolism predict midterm clinical outcome in end-stage heart failure patients. Scand Cardiovasc J 45:342–348
7. Mahfoud F, Kindermann I, Kindermann M, Ukena C, Böhm M (2009) Comorbidity: anemia and heart failure. Dtsch Med Wochenschr 134:825–830 [in German]
8. Radovancevic B, Bracey AW, Riggs SA, Radovancevic R, Frazier OH (2001) Left ventricular assist devices and bleeding diathesis: hematological and medical issues. J Congest Heart Failure Circ Support 2:13–17
9. Ronco C, Cozzolino M (2012) Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes. Heart Fail Rev 17:211–220
10. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W (2008) Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340–1349
11. Pilz S, Tomaschitz A, Drechsler C, Zittermann A, Dekker JM, März W (2011) Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets 12:88–96
12. Zittermann A, Börgermann J, Gummert JF, Pilz S (2012) Future directions in vitamin D and cardiovascular research. Nutr Metab Cardiovasc Dis 22:541–546
13. Lutsey PL, Alonso A, Selvin E, Pankow JS, Michos ED, Agarwal SK, Loehr LR, Eckfeldt JH, Coresh J (2014) Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the atherosclerosis risk in communities study. J Am Heart Assoc 3:e000936
14. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK (2009) INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 28:535–541
15. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Timothy Baldwin J, Young JB (2013) Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 32:141–156
16. Tuñón J, Cristóbal C, Tarín N, Aceña Á, González-Casaus ML, Huelmos A, Alonso J, Lorenzo Ó, González-Parra E, Mahíllo-Fernández I, Pello AM, Carda R, Farré J, Rodríguez-Artalejo F, López-Bescós L, Egido J (2014) Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease. PLoS One 9:e95402
17. DGE (German Nutrition Society), Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung (2012) D-ACH-Referenzwerte für die Nährstoffzufuhr, 1. Auflage, 5., korrigierter Nachdruck 2013, Neuer Umschau Buchverlag, Neustadt an der Weinstraße
18. Yuan C, Kosewick J, He X, Kozak M, Wang S (2011) Sensitive measurement of serum 1α,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun Mass Spectrom 25:1241–1249
19. Zittermann A, Jungvogel A, Prokop S, Kuhn J, Dreier J, Fuchs U, Schulz U, Gummert JF, Börgermann J (2011) Vitamin D deficiency is an independent predictor of anemia in end-stage heart failure. Clin Res Cardiol 100:781–788
20. Zittermann A, Schleithoff SS, Götting C, Fuchs U, Kuhn J, Kleesiek K, Tenderich G, Koerfer R (2009) Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation 87:118–124
21. Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, Shlipak MG, Whooley MA, Ix JH (2010) The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med 152:640–648
22. Sindermann JR, Scherer M, Hoffmeier A (2013) Thromboembolische Komplikationen am VAD. In: Boeken U, Assmann A, Born F, Schmid C (eds) Mechanische Herz-Kreislauf-Unterstützung. Springer, Berlin, pp 301–305
23. Amrein K, Quraishi SA, Litonjua AA, Gibbons FK, Pieber TR, Camargo CA Jr, Giovannucci E, Christopher KB (2014) Evidence for a U-shaped relationship between prehospital vitamin D status and mortality: a cohort study. J Clin Endocrinol Metab 99:1461–1469
24. Zittermann A (2010) The estimated benefits of vitamin D for Germany. Mol Nutr Food Res 54:1164–1171
25. Schilling S (2012) Epidemic vitamin D deficiency among patients in an elderly care rehabilitation facility. Dtsch Arztebl Int 109:33–38
26. Pilz S, Dobnig H, Fischer JE, Wellnitz B, Seelhorst U, Boehm BO, März W (2008) Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke 39:2611–2613
27. Zittermann A (2003) Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89:552–572
28. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29:726–776
29. Hyppönen E, Berry D, Cortina-Borja M, Power C (2010) 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. PLoS One 5:e10801
30. Zittermann A, Prokop S, Gummert JF, Börgermann J (2013) Safety issues of vitamin D supplementation. Anticancer Agents Med Chem 13:4–10
31. Lindqvist PG, Epstein E, Olsson H (2009) Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis. J Thromb Haemost 7:605–610
32. Beer TM, Venner PM, Ryan CW, Petrylak DP, Chatta G, Dean Ruether J, Chi KN, Curd JG, DeLoughery TG (2006) High dose calcitriol may reduce thrombosis in cancer patients. Br J Haematol 135:392–394
33. Ranch D, Zhang MY, Portale AA, Perwad F (2011) Fibroblast growth factor 23 regulates renal 1,25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice. J Bone Miner Res 26:1883–1890
34. Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y, Fukushima S, Saito T, Daimon T, Ueno T, Kuratani T, Sawa Y (2012) Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function. Circ J 76:1631–1638
35. Barge-Caballero E, Paniagua-Martín MJ, Marzoa-Rivas R, Campo-Pérez R, Rodríguez-Fernández JÁ, Pérez-Pérez A, García-Bueno L, Blanco-Canosa P, Cancela ZG, Solla-Buceta M, Juffé-Stein A, Herrera-Noreña JM, Cuenca-Castillo JJ, Muñiz J, Castro-Beiras A, Crespo-Leiro MG (2011) Usefulness of the INTERMACS scale for predicting outcomes after urgent heart transplantation. Rev Esp Cardiol (Engl Ed) 64:193–200
36. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S (2012) Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 95:91–100
37. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1:CD007470. doi:10.1002/14651858.CD007470.pub3
38. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB, Franco OH (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348:g1903
39. Zittermann A, Ernst JB, Gummert JF, Börgermann J (2014) Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr 53:367–374
40. Gallacher KI, Batty GD, McLean G, Mercer SW, Guthrie B, May CR, Langhorne P, Mair FS (2014) Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden. BMC Med 12:151